A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
This study has been completed.
Study NCT00001136
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: January 25, 2000
Last Updated: September 26, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
